Market Place
Sourcing Support
We are pleased to announce that the USDMF for Desvenlafaxine Succinate has been submitted to the USFDA.
08 Mar 2023 //
PRESS RELEASE
Intellipharmaceutics` Generic Desvenlafaxine Receives Approval in US
08 Feb 2019 //
FDA
Yichang Humanwell`s Generic Desvenlafaxine Succinate Receives Approval in US
03 Oct 2018 //
FDA
Alembic Pharma gets USFDA nod for depressive disorder drug
17 Sep 2018 //
ECONOMIC TIMES
Zydus Pharm’s Generics Desvenlafaxine Succinate Receives Approval In US
13 Oct 2017 //
FDA
Pfizer faces first 2017 patent loss as Pristiq generics crash the party
11 Mar 2017 //
FIERCE PHARMA
Alembic Pharma`s partner launches drug for depressive disorder
04 Mar 2017 //
ECONOMIC TIMES
Lupin launches generic drug to treat depression in US
02 Mar 2017 //
ECONOMIC TIMES
Intellipharmaceutics Signs License and Commercial Supply Pact with Mallinckrodt
11 Oct 2016 //
GLOBENEWSWIRE
Pfizer Hikes Prices on 121 Drugs, Report Says
19 Jan 2016 //
PHARMACEUTICAL PROCESSING
Merck`s Keytruda line up its survival data,stepped-up battle with BMS` Opdivo
21 Dec 2015 //
BIOSPACE
Lupin`s Generic Desvenlafaxine Succinate Approved in US For MDD
02 Jul 2015 //
FDA
Pfizer`s Pristiq fails in paediatric study
12 Jun 2015 //
PHARMATIMES
Pfizer`s Phase 3 Study of Pristiq in MDD Misses Primary Endpoint
05 Jan 2015 //
DDD
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.